Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Syndesi Therapeutics

Syndesi Therapeutics
2018 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$21M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of drug molecules designed to treat cognitive impairment. The company's drug molecules can modulate the synaptic vesicle protein SV2A to handle synaptic transmission, enabling doctors to treat Alzheimer's Disease and other disorders with cognitive impairment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Centre d'Entreprises et d'Innovation (CEI) Incubator
  • Chemin du Cyclotron 6
  • 1348 Louvain-la-Neuve
  • Belgium

+32 010 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Syndesi Therapeutics’s full profile, request a free trial.

Syndesi Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 01-Feb-2018 $21M 0000 Completed Startup
1. Accelerator/Incubator 01-Jan-2018 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Syndesi Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Fountain Healthcare Partners Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
Société Régionale d'Investissement de Wallonie Growth/Expansion Minority 000 0000 000000 0
UCB Corporation Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Syndesi Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Jonathan Savidge Ph.D Founder & Chief Executive Officer
John Kemp Ph.D Chief Scientific Officer
Charlotte Videbaek MD Chief Medical Officer

Syndesi Therapeutics Board Members (5)

Name Representing Role Since Contact
Info
Aidan King Fountain Healthcare Partners Board Member 000 0000
Christina Takke Ph.D V-Bio Ventures Board Member 000 0000
Emmanuel Lacroix Ph.D UCB Board Member 000 0000
Maciek Drozdz Ph.D Johnson & Johnson Innovation - JJDC Board Member 000 0000
Morten Døssing Novo Holdings Board Member 000 0000